| BRIEF COMMUNICATION |
|
| Year : 2011 | Volume
: 15
| Issue : 7 | Page : 248-249 |
|
|
Growth hormone in male infertility
Navneet Magon1, Suneeta Singh2, Ajit Saxena3, Rakesh Sahay4
1 Department of Obstetrics and, Gynecology, Air Force Hospital, Kanpur, India
2 Department of Obstetrics and Gynecology, Military Hospital, Mhow, Madhya Pradesh, India
3 Department of Urology and Andrology, Indraprastha Apollo Hospitals, Delhi, India
4 Department of Endocrinology, Osmania Medical College and Osmania General Hospital, Hyderabad, Andhra Pradesh, India
Correspondence Address:
Navneet Magon
Obstetrician, Gynecologist and Endoscopic Surgeon, Department of Obstetrics and Gynecology, Air Force Hospital, Kanpur, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2230-8210.84877
|
|
|
Growth hormone (GH) is expressed in a variety of tissues, including the testes, and has autocrine and paracrine functions as well. This, along with other factors, exerts autocrine and paracrine control over spermatogenesis. GH, used as an adjuvant therapy, induces spermatogenesis in non-responder patients with hypogonadotropic hypogonadism, who are not responding to gonadotropin or pulsatile luteinizing hormone (LH) therapy. GH has an important physiological role to play in spermatogenesis and male fertility. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
